ArticlePharmacoepidemiology and drug safety2026
Trends in Pharmacist-Prescribed Dispensing Records of HIV Pre-Exposure (2020-2025) and Post-Exposure Prophylaxis (2020-2024) in Brazil: A Time Series Analysis.
Article in Pharmacoepidemiology and drug safety, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposePharmacist prescribing of HIV pre-exposure (PrEP) and post-exposure prophylaxis (PEP) is an emerging strategy to expand access to HIV prevention, but real-world evidence on its implementation remains limited. We assessed national and regional trends in pharmacist-prescribed dispensing records of PrEP (2020-2025) and PEP (2020-2024) in Brazil.
methodsNationwide time series analysis using databases from the Ministry of Health. The primary outcome was pharmacist-prescribed PrEP and PEP dispensing records per 100 000 adults per year. Joinpoint regression was used to estimate average annual percent change (AAPC) and 95% confidence intervals (95% CIs).
resultsPharmacists prescribed 27 126 (2.80%) of 969 536 PrEP records and 13 073 (1.97%) of 664 000 PEP records. The frequency of pharmacist-prescribed records in relation to all prescribers increased (PrEP: 0.22% to 5.77%; PEP: 0.12% to 4.59%). National pharmacist-prescribed PrEP dispensing increased from 0.10 to 6.24 per 100 000 adults (AAPC: 120.80; 95% CI 71.96 to 189.84; p < 0.001), while pharmacist-prescribed PEP dispensing increased from 0.07 to 4.93 per 100 000 adults (AAPC: 166.62; 95% CI 68.66 to 313.26; p < 0.001). The Southeast had the highest absolute rates for both strategies. Significant upward trends were observed in all five regions for PrEP, and in the Southeast, Northeast, and Center-West for PEP. The national PrEP rate stabilized between 2024 and 2025.
conclusionsPharmacist prescribing of HIV prophylactic medications significantly increased in Brazil since 2020 and may potentially represent an important mechanism to broaden access to HIV prevention. However, regional differences may underscore the need for targeted policy interventions to address geographic implementation gaps.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.